SOLUPREP S Drug Patent Profile
✉ Email this page to a colleague
When do Soluprep S patents expire, and what generic alternatives are available?
Soluprep S is a drug marketed by 3m Health Care and is included in one NDA.
The generic ingredient in SOLUPREP S is chlorhexidine gluconate; isopropyl alcohol. There are fifty-eight drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the chlorhexidine gluconate; isopropyl alcohol profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for SOLUPREP S?
- What are the global sales for SOLUPREP S?
- What is Average Wholesale Price for SOLUPREP S?
Summary for SOLUPREP S
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Clinical Trials: | 4 |
| DailyMed Link: | SOLUPREP S at DailyMed |
Recent Clinical Trials for SOLUPREP S
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Centre for Interdisciplinary Research in Rehabilitation of Greater Montreal | Phase 4 |
| Claire Bourgeois | Phase 4 |
| Fédération des médecins résidents du Québec | Phase 4 |
Pharmacology for SOLUPREP S
| Physiological Effect | Decreased Cell Wall Integrity |
US Patents and Regulatory Information for SOLUPREP S
SOLUPREP S is protected by zero US patents and one FDA Regulatory Exclusivity.
FDA Regulatory Exclusivity protecting SOLUPREP S
REVISIONS TO THE LABELING TO DESCRIBE MODIFIED FORMULATION BASED ON RESULTS OF STUDIES EM-05-014624 AND EM-05-014815
Exclusivity Expiration: ⤷ Sign Up
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3m Health Care | SOLUPREP S | chlorhexidine gluconate; isopropyl alcohol | SOLUTION;TOPICAL | 208288-001 | Aug 8, 2018 | OTC | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for SOLUPREP S
See the table below for patents covering SOLUPREP S around the world.
| Country | Patent Number | Title | Estimated Expiration |
|---|---|---|---|
| Japan | 2011507978 | ⤷ Sign Up | |
| Canada | 2711217 | COMPOSITIONS ANTIMICROBIENNES (ANTIMICROBIAL COMPOSITIONS) | ⤷ Sign Up |
| China | 101951779 | Antimicrobial compositions | ⤷ Sign Up |
| World Intellectual Property Organization (WIPO) | 2009088894 | ⤷ Sign Up | |
| European Patent Office | 2625957 | Compositions antimicrobiennes (Antimicrobial compositions) | ⤷ Sign Up |
| Brazil | PI0819567 | "composições antimicrobianas, método para aprimorar a adesão molhada do artigo adesivo médico e método para evitar ou tratar uma condição da pele de um mamífero | ⤷ Sign Up |
| >Country | >Patent Number | >Title | >Estimated Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
